middle.news
Beamtree’s sharper portfolio opens a new test after 10% recurring revenue growth
9:37am on Friday 23rd of October, 2026 AEDT
•
Healthcare technology
Read Story
Beamtree’s sharper portfolio opens a new test after 10% recurring revenue growth
9:37am on Friday 23rd of October, 2026 AEDT
Key Points
Recurring revenue rose 10% to A$27.5 million
Statutory loss widened to A$18.3 million after A$13.1 million impairment
Operating profit was A$362,000 and EBITDA A$310,000
BNZ waived a 30 June recurring revenue covenant breach
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Beamtree (ASX:BMT)
OPEN ARTICLE